A source familiar with the move told CNN that the United States bought and will donate five hundred million doses of Pfizer’s coronavirus vaccine globally as the country seeks to be a key player in getting other countries vaccinated. The person said that Joe Biden, the President of the U.S., will announce the news regarding the vaccine donations at the G7 summit in Cornwall, England.
The United States of America is set to donate 500 million doses of Pfizer’s COVID-19 vaccine to the world.
According to reports the U.S. will donate the doses to 92 low-income countries and the African Union. pic.twitter.com/UyfkTK6n96
— This Is Africa (@ThisIsAfricaTIA) June 10, 2021
The U.S. will send about two hundred million doses of vaccine outside in 2021, and three hundred million will distribute in the initial half of 2022. Jeff Zients, the leading coronavirus adviser of president Biden, is working on the deal for the last month. All doses will go through COVID-19 Vaccines Global Access (COVAX), the global vaccine initiative, and will go to ninety-two low-and-lower-income nations, along with the African Union.
Jake Sullivan, the national security adviser of White House, told reporters on-board Air Force One on Wednesday that besides the Pfizer acquisition, the president also expected to contribute in a combined announcement with the G7 on a wide-ranging plan to end the coronavirus pandemic. It will include a section on COVID-19 vaccines.
Biden Previously Committed to Sharing Eighty Million Vaccine Doses
Furthermore, Sullivan argued that having America play a top role in international coronavirus vaccine distribution is part of what American nationals do in times of need and would be valuable to prevent the upcoming spread of the virus in the country. He further adds that he does want to show gathering the rest of the democracies of the world – the democracies are the nations that can best bring solutions for people everywhere.
The U.S. president previously committed to sharing eighty million coronavirus vaccine doses with other nations. That share includes doses of the Pfizer vaccine as well. Last week, the Biden government announced its plan to share the initial twenty-five million coronavirus vaccine doses with the rest of the world nations and a general framework of distributing at least eight million doses by June end.
The White House also said at least seventy-five percent of those donated virus vaccines will be shared with the worldwide vaccination program called (COVAX) COVID-19 Vaccines Global Access, and twenty-five percent will be shared straight with nations in need. Last month, President Biden said the United States would share another twenty million COVID-19 vaccine doses by June end on top of the sixty million doses of AstraZeneca vaccine Biden had already committed to sharing by 4th July.
Moreover, the additional twenty million doses will consist of Pfizer, Johnson & Johnson, and Moderna vaccines in addition to AstraZeneca, which federal regulators approved before they shipped overseas. Biden said there would be enough coronavirus vaccine supply for every adult American national by June end and aim to have seventy percent of American adults vaccinated by 4th July. However, the U.S. remains on the way to fall short of the goal.
U.S. Deal at the Group of Seven Meeting of Wealthiest Countries in Britain
On Thursday, Joe Biden will announce at the Group of Seven meetings of the wealthiest nations of the world in Britain, according to a familiar source. Jeff Zients, the White House coronavirus response coordinator, and the COVID-19 task force team negotiated the deal over the past month. On Wednesday, CNBC reported that America is also talking with Moderna biotechnology company about acquiring some of its shots to donate to other nations.
According to a spokesman of Moderna Inc., the company aimed to possibly provide the American government with coronavirus shots to give to low-and-middle-income nations but denied to comment on any discussions. On the other hand, Pfizer and the White House declined to comment. Pfizer said that it expects to make as many as three billion coronavirus vaccine shots in 2021 and upwards of four billion next year.